Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma
Condition(s):Advanced MelanomaLast Updated:July 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced MelanomaLast Updated:July 6, 2023Not yet recruiting
Condition(s):Polycythemia VeraLast Updated:August 3, 2023Completed
Condition(s):Polycythemia VeraLast Updated:June 1, 2021Completed
Condition(s):Polycythemia VeraLast Updated:July 20, 2012Terminated
Condition(s):Advanced MelanomaLast Updated:July 6, 2023Not yet recruiting
Condition(s):Atrial FibrillationLast Updated:March 18, 2020Completed
Condition(s):HCCLast Updated:June 15, 2023Active, not recruiting
Condition(s):Heart Defects, Congenital; Tetralogy of Fallot; Pulmonary Valve Insufficiency; Pulmonary Valve StenosisLast Updated:February 16, 2024Active, not recruiting
Condition(s):Congenital Heart DiseaseLast Updated:April 8, 2021Unknown status
Condition(s):DysphoniaLast Updated:October 24, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.